PMID- 34267861 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220424 IS - 1942-2962 (Print) IS - 1942-2970 (Electronic) IS - 1942-2962 (Linking) VI - 14 IP - 2 DP - 2021 Jun TI - Clinical Pharmacist Outreach to Increase Statin Use for Patients with Cardiovascular Disease in a Safety-Net Healthcare System. PG - 63-69 AB - BACKGROUND: Statin Therapy for Patients with Cardiovascular Disease (SPC) is a Centers for Medicare & Medicaid Services Star measure added to Medicare Part C (Medicare Advantage) plans in 2019 to incentivize statin use for secondary prevention of cardiovascular disease (CVD). The measure assesses statin dispensing and adherence in patients with atherosclerotic CVD (ASCVD). Clinical pharmacists are well-positioned to affect positively a health system's performance on the SPC measure. OBJECTIVE: To assess the effect of telephone outreach by clinical pharmacists on moderate- or high-intensity statin prescribing in patients with ASCVD. METHODS: Patients in managed care health plans who meet the SPC measure criteria and are not currently receiving a moderate- to high-intensity statin therapy were contacted by a clinical pharmacist through telephone outreach. If appropriate, they were prescribed a statin by a clinical pharmacist. The primary outcome measure was the proportion of patients who meet the SPC measure classification and had 1 confirmed prescription fill for a moderate- or high-intensity statin after intervention by a clinical pharmacist. RESULTS: A total of 84 patients were identified for review and outreach, of whom 35 (41.7%) met the SPC measure criteria. Of these 35 patients, 16 (45.7%) were female and the mean age was 66 years. A total of 22 (62.9%) patients agreed to a statin prescription, and 16 (72.7%) of these patients picked up the prescription within 10 days of prescribing. An additional 4 patients, for a total of 20 (57.1%) of the 35 eligible patients, were eventually dispensed a statin. Healthcare Effectiveness Data and Information Set (HEDIS) vendor data available after the intervention showed a larger SPC measure population than was captured with the health plan's internal report. HEDIS data showed an increase in statin prescribing for patients meeting the SPC measure classification from 24.7% to 56.6% during the study period (P <.001). The mean time spent per patient for chart review and/or outreach by the clinical pharmacist was 27.7 (standard deviation, 9) minutes. CONCLUSION: These results indicate that clinical pharmacists who conduct a telephonic population health intervention can achieve a high rate of success in initiating a moderate- to high-intensity statin therapy in patients with ASCVD. CI - Copyright (c) 2021 by Engage Healthcare Communications, LLC. FAU - Cornelison, Paul AU - Cornelison P AD - Clinical Pharmacist, Evans Army Community Hospital, and was PGY2 Ambulatory Care Resident, Denver Health Medical Center, during this study. FAU - Marrs, Joel C AU - Marrs JC AD - Associate Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, and was Clinical Pharmacy Specialist, Denver Health Medical Center during this study. FAU - Anderson, Sarah L AU - Anderson SL AD - Associate Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, and was Clinical Pharmacy Specialist, Denver Health Medical Center during this study. LA - eng PT - Journal Article PL - United States TA - Am Health Drug Benefits JT - American health & drug benefits JID - 101479877 PMC - PMC8244736 OTO - NOTNLM OT - SPC measure OT - atherosclerotic cardiovascular disease OT - clinical pharmacists OT - medication prescribing OT - safety net healthcare system OT - statin therapy OT - telephone intervention EDAT- 2021/07/17 06:00 MHDA- 2021/07/17 06:01 PMCR- 2021/06/01 CRDT- 2021/07/16 06:38 PHST- 2020/06/14 00:00 [received] PHST- 2020/11/12 00:00 [accepted] PHST- 2021/07/16 06:38 [entrez] PHST- 2021/07/17 06:00 [pubmed] PHST- 2021/07/17 06:01 [medline] PHST- 2021/06/01 00:00 [pmc-release] PST - ppublish SO - Am Health Drug Benefits. 2021 Jun;14(2):63-69.